Search Results
467 results found for 'coronavirus':
221. Cyprus ranks second among EU countries in terms of coronavirus testing
05-02-2021 12:51
Cyprus ranks high in relation to testing among the 27 member states of the European Union. According to recent data from the European Centre for Disease Prevention and Control(ECDC – Week 4), Cyprus r...
222. EMA starts rolling review of Novavax’s COVID-19 vaccine (NVX-CoV2373)
04-02-2021 08:04
EMA’s human medicines committee (CHMP) has started a rolling review of NVX-CoV2373, a COVID‑19 vaccine being developed by Novavax CZ AS (a subsidiary of Novavax, Inc.). The CHMP’s decision to start th...
223. Revised list of private laboratories for the new coronavirus (SARS-CoV-2) molecular test
03-02-2021 17:24
The Ministry of Health announces a revised list of private Clinical Laboratories which have verified the procedure of conducting the diagnostic methodology that detects the genetic material of the vir...
224. Registered unemployed: January 2021
03-02-2021 13:09
The unemployed persons, registered at the District Labour Offices on the last day of January 2021, reached 32.333 persons. Based on the seasonally adjusted data that show the trend of unemployment, th...
225. Answers to frequently-asked questions on COVID-19 Vaccine AstraZeneca
29-01-2021 18:14
COVID-19 Vaccine (ChAdOx1-S [recombinant]) 1. What is COVID-19 Vaccine AstraZeneca and what is it used for? COVID-19 Vaccine AstraZeneca is a vaccine for preventing coronavirus disease 2019 (COVID-...
226. EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU
29-01-2021 18:11
EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca to prevent coronavirus disease 2019 (COVID-19) in people from 18 years of age. This is the third COV...
227. COVID-19 vaccine safety update for Comirnaty
29-01-2021 12:28
Marketing authorisation holder: BioNTech Manufacturing GmbH Key Messages The latest safety data for this vaccine are in line with the known side effect profile, and the related reviews are presented i...
228. Clarification of Comirnaty dosage interval
29-01-2021 12:26
EMA’s human medicines committee (CHMP) has updated the product information for the COVID-19 vaccine Comirnaty to clarify its position on the interval between the first and second dose. The product inf...
229. First COVID-19 vaccine safety update published
29-01-2021 12:23
Today EMA has released its first safety update on a COVID-19 vaccine – Comirnaty. It concludes that safety data collected on Comirnaty use in vaccination campaigns is consistent with the known safety ...
230. The measures relating to flights and airports shall be extended until 1st March 2021
27-01-2021 14:37
The Ministry of Transport, Communications and Works announces that during today’s meeting, the Council of Ministers decided to extend the existing measures applicable to flights and airports of the Re...
PRESS AND INFORMATION OFFICE
